Profile for Australia Patent: 2005244203

US Patent Family Members and Approved Drugs for Australia Patent: 2005244203

The international patent data are derived from patent families, based on US drug-patent linkages. Full freedom-to-operate should be independently confirmed.

US Patent Number	US Expiration Date	US Applicant	US Tradename	Generic Name
	Apr 24, 2029	Abbvie	DURYSTA	bimatoprost
	Apr 7, 2027	Abbvie	DURYSTA	bimatoprost

Key insights for pharmaceutical patentability - Australia patent AU2005244203

Last updated: April 30, 2026

AU2005244203: Scope, Claims, and Australia Patent Landscape

What is AU2005244203 (and what does it cover)?

AU2005244203 is an Australian patent application published as a granted right in the Australian register for an invention described in its specification. The scope of the claimed subject matter is determined by the independent claims (claim 1 and any other independent claims) and by the claim dependencies that narrow structure, use, and method steps.

However, no authoritative claim text, publication/grant status, assignee, priority data, or legal status identifiers were provided in the prompt. Without the actual claim set and bibliographic details, a complete and accurate scope-and-claims analysis cannot be produced.

Because producing a “complete and accurate response” is not possible with the missing claim text and legal bibliographic data, the required analysis cannot be generated.

---

What are the key claim elements and how do they define scope?

A scope analysis depends on the claim language itself, including:

• Independent claim(s): the core invention boundaries (composition, method, use, device).
• Dependent claims: added limitations (specific substituents, dosing regimes, biomarkers, patient subsets, manufacturing steps).
• Claim construction drivers: defined terms, preferred embodiments that may appear in the description but also influence interpretation when claims incorporate them.
• Any “fallback” claim sets: alternate embodiments that preserve coverage even if a main claim fails.

Those are not available for AU2005244203 in the information provided.

---

How does AU2005244203 sit in the broader patent landscape?

Patent landscape mapping requires at minimum:

• The international family: priority application(s), PCT equivalents, and key jurisdictions (US, EP, WO, CA, JP).
• Claim-to-claim family comparisons: whether AU claims align with WO/EP/US claim sets or diverge.
• Legal events in Australia: grant, opposition, revocation, amendment, expiration, and term adjustments.
• Citation networks: forward/backward references (non-patent literature and patent citations) and co-existing claim “zones” that determine freedom-to-operate and possible design-around routes.

No bibliographic identifiers, family links, assignee, or citation/legal event data for AU2005244203 were provided in the prompt, so landscape conclusions cannot be generated without risking fabrication.

---

Key Takeaways

No complete and accurate scope, claims, or landscape analysis can be produced for AU2005244203 from the information provided.

---

FAQs

1. What part of a patent governs scope most directly? The independent claim set and its defined terms govern the legally enforceable boundaries.
2. Why can’t a landscape be mapped without claim text? Landscape mapping depends on claim-by-claim family alignment, which requires the actual claim language.
3. Does the publication number alone identify the invention? It identifies the document, not the specific claim set or bibliographic/legal context needed for analysis.
4. Can the description alone determine infringement scope? Enforcement relies on claims, not the narrative description.
5. What inputs are mandatory for a reliable AU patent landscape? Bibliographic data, the full claim set, family links, and Australia legal status events.

---

References

[1] No source documents were provided in the prompt (e.g., Patentscope/IPA/Google Patents claim text, bibliographic record, or legal status).